Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study.
Natsu Otowa-SuematsuKazuhiko SakaguchiTomoaki NakamuraKenta HaraMinoru KishiNaoko HashimotoKazuki YokotaHiroshi YoshinoYasuo KurokiTomoko NishiumiAnna SouHisako KomadaYuko OkadaYushi HirotaYoshikazu TamoriWataru OgawaPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)
This trial has been registered with UMIN (No. 000010769).